HB8530, titled the Quantum for Health Act, amends the National Quantum Initiative Act to broaden the federal quantum initiative beyond core science and technology research and to explicitly connect it to health, social benefit, workforce development, and other applied sectors. The bill revises the stated purposes of the initiative, expands the scope of the National Quantum Initiative Program to include applications in diverse sectors, and updates the roles of the National Quantum Coordination Office and related advisory bodies to reflect science, engineering, technology research, and workforce coordination.
The bill also adds the Department of Health and Human Services to key quantum science and economic/security subcommittees, signaling a stronger federal link between quantum information science and health-related policy and research. It increases the authorized number of multidisciplinary centers for quantum research and education from 5 to 10, broadens the subject matter these centers may cover, and requires outreach plans aimed at increasing participation by women and other historically underrepresented groups in STEM. Overall, the measure seeks to steer quantum policy toward broader public-interest uses while strengthening education and workforce pipelines.
Impact
If enacted, the bill would amend multiple sections of the National Quantum Initiative Act, expanding federal quantum policy to include health, social benefit, and workforce considerations and requiring broader interagency and nonprofit participation. It would affect the structure and duties of the National Quantum Coordination Office, the advisory committee, and the quantum subcommittees, while also increasing the number and scope of federally supported multidisciplinary quantum centers. The bill would primarily affect federal agencies, universities, nonprofit research organizations, and STEM education and workforce stakeholders, with a particular emphasis on health-related applications and inclusion efforts.
Sentiment
The available context suggests a generally positive and forward-looking framing of the bill, with the title and text emphasizing health applications, workforce development, and broader societal benefits from quantum research. Because there are no committee transcripts or recorded votes provided, there is no evidence of formal opposition or support beyond the bill’s introduction and referral. The measure appears to be presented as an expansion and modernization of the existing quantum initiative rather than a controversial policy shift.
Contention
The bill’s main points of potential contention are likely to be the expansion of federal quantum priorities into health and social benefit areas, the increased role of the Department of Health and Human Services, and the larger number of authorized research centers. Some stakeholders could question whether the initiative should remain focused on foundational quantum science versus broader applied and workforce goals, or whether the added mandates and coordination requirements create administrative complexity. The inclusion of outreach requirements for underrepresented groups may also draw attention from those debating how federal research programs should address diversity and participation goals.
A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions. (Formerly HSB 25.) Effective date: 03/28/2025.
A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions.(See SF 305.)
A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions.(See HF 182.)